全球上游生物加工市场 – 行业趋势及 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球上游生物加工市场 – 行业趋势及 2029 年预测

  • Healthcare
  • Upcoming Report
  • Jul 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Upstream Bioprocessing Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 8,391.22 Million
Diagram Market Size (Forecast Year)
USD 14,256.78 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>全球上游生物加工市场,按产品(生物反应器/发酵罐、细胞培养产品、过滤器、生物反应器配件、袋子和容器等)、工作流程(培养基制备、细胞培养和细胞分离)、使用类型(多次使用和一次性使用)、模式(内部和外包)划分——行业趋势和预测至 2029 年

上游生物加工市场

市场分析和规模

细胞系生产力的提高,有意识地提高了上游加工的性能,成本低,工艺可重复性高。生物工艺的第一步是上游生物加工,用于生成细胞系并对其进行培养,以便通过收获使细胞生长。

Data Bridge Market Research 分析,上游生物加工市场在 2021 年为 83.9122 亿美元,到 2029 年将飙升至 142.5678 亿美元,预计在 2022 年至 2029 年的预测期内复合年增长率为 6.85%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制为 2014 - 2019)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

产品(生物反应器/发酵罐、细胞培养产品、过滤器、生物反应器配件、袋子和容器等)、工作流程(培养基制备、细胞培养和细胞分离)、使用类型(多次使用和一次性使用)、模式(内部和外包)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

赛默飞世尔科技公司(美国)、通用电气公司(美国)、默克公司(德国)、康宁公司(美国)、赛多利斯公司(德国)、Eppendorf SE(德国)、龙沙公司(瑞士)、PBS Biotech 公司(美国)、Sartorius CellGenix GmbH(德国)、勃林格殷格翰国际有限公司(德国)、三星生物制剂公司(韩国)、Patheon NV(美国)、AGC Biologics(丹麦)、丹纳赫公司(美国)、Hash Biotech Labs(印度)

市场机会

  • 不断增长的生物仿制药和生物分子
  • 慢性病患病率不断上升

市场定义

The production of biopharmaceuticals, also referred to as bioprocessing, is a bioprocess engineering application utilized in the culture of therapeutic cells. End products from bioprocessing have a high value and are utilized to achieve particular goals. Upstream and downstream biopharmaceutical manufacturing are the two types of processes utilized in the production of biopharmaceuticals.

Upstream Bioprocessing Market Dynamics

Drivers

  • Rise in chronic disease prevalence

The rise in chronic disease prevalence, more effective treatments using cutting-edge technology and high-quality biologic pharmaceuticals are being produced. Due to these causes, the market for upstream bioprocessing is expanding and upstream processing equipment consumption has expanded. A few other key factors for the expansion of the upstream bioprocessing market are drug development, antibody manufacturing, an increase in the need for cell therapy research.

  • Increase in research into the production of biosimilar

The market for upstream bioprocessing is being pushed by an increase in research into the production of biosimilars/biomolecules, monoclonal antibodies, and tiny therapeutic peptides. The demand for process improvement and clean, secure, and effective biomolecule production fuels the market's expansion.

  • Research and development activities

Growing biosimilars and biomolecule research and development is a key element fuelling the global market expansion. Globally, the prevalence of chronic diseases is rising, which is anticipated to fuel the global market's expansion in the future.

Opportunities

The usual transition from simple stainless-steel bioreactors to single-use products has prompted manufacturing advantages for upstream applications. Additionally, market competitors are concentrating on cumulative manufacturing of single-use technology due to the growing usage of this technology. For instance, Sartoius Sedium Biotech was chosen by Abzena Company, a biopharmaceutical manufacturer, to develop its Bristol-based production facility for single-use format. This element is therefore anticipated to increase the upstream bioprocessing market applicability in the near future.

Restraints/Challenges

  • High cost

The high cost of processing unit setup and maintenance would be a barrier to the expansion of the upstream bioprocessing market during the forecast period.

本上游生物加工市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关上游生物加工市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

全球上游生物加工市场范围

上游生物加工市场根据产品、工作流程、使用类型和模式进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

产品

  • 生物反应器/发酵罐
  • 细胞培养产品
  • 筛选器
  • 生物反应器配件
  • 袋子和容器
  • 其他的

工作流

  • 媒体准备
  • 细胞培养
  • 细胞分离

使用类型

  • 多用途
  • 一次性使用

 模式

  • 内部
  • 外包

上游生物加工市场区域分析/见解

对上游生物加工市场进行了分析,并按国家、产品、工作流程、使用类型、模式提供了市场规模见解和趋势。

上游生物加工市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

北美凭借其最大的上游生物加工市场份额,主导着上游生物加工市场。

由于越来越多的参与者关注新兴市场的增长潜力,亚太地区上游生物加工市场将出现最高增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和上游生物加工市场份额分析

上游生物加工市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对上游生物加工市场的关注有关。

上游生物加工市场的一些主要参与者包括:

  • 赛默飞世尔科技公司(美国)
  • 通用电气(美国)
  • 默克集团(德国)
  • 康宁公司(美国)
  • Sartorius AG(德国)
  • Eppendorf SE(德国)
  • 龙沙(瑞士)
  • PBS Biotech, Inc.(美国)
  • Sartorius CellGenix GmbH(德国)
  • 勃林格殷格翰国际有限公司 (德国)
  • 三星生物制剂(韩国)
  • Patheon NV(美国)
  • AGC Biologics(丹麦)
  • 丹纳赫(美国)
  • Hash Biotech Labs(印度)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Upstream Bioprocessing Market will be worth USD 14256.78 million by 2029 during the forecast period.
The Upstream Bioprocessing Market growth rate is 6.85% during the forecast period.
Rise in chronic disease prevalence, Increase in research into the production of biosimilar and Research and development activities are the growth drivers of the Upstream Bioprocessing Market.
The product, workflow, use type, mode are the factors on which the Upstream Bioprocessing Market research is based.
Major companies in the Upstream Bioprocessing Market are Thermo Fisher Scientific, Inc. (U.S.), General Electric (U.S.), Merck KGaA (Germany), Corning Incorporated (U.S.), Sartorius AG (Germany), Eppendorf SE (Germany), Lonza (Switzerland), PBS Biotech, Inc. (U.S.), Sartorius CellGenix GmbH (Germany), Boehringer Ingelheim International GmbH (Germany), Samsung Biologics (South Korea), Patheon N.V (U.S.), AGC Biologics (Denmark), Danaher (U.S.), Hash Biotech Labs (India).